Among CNS tumors, PPM1D has been found to be a good prognostic marker for diffuse midline gliomas (Khadka et al., 2022), younger supratentorial diffuse astrocytic tumors, and oligodendroglial tumors (Jeong et al., 2018). This evidence concerns the gene PPM1D and diffuse midline glioma.